ENOUGH
Susanne Wiegel is an experienced professional in business development and alternative protein initiatives, currently serving as a Board Observer for ENOUGH, Roslin Technologies, and BlueNalu, while also leading the Alternative Protein Program at Nutreco since October 2019. Prior experience includes a role as Senior Director and Deputy Head of Business Development at MorphoSys AG from 2008 to 2019, and as Manager of Business Development at Medigene AG. Earlier in their career, Susanne Wiegel worked as an Associate at McKinsey & Company. Academically, Susanne Wiegel holds a Ph.D. in Structural Biology from the Helmholtz Centre for Infection Research and a Diplom in Biochemistry from Leibniz Universität Hannover.
This person is not in any teams
This person is not in any offices
ENOUGH
ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). Thisgives integrated fermentation production of Food, Fuel and Feed.